×
About 405 results

ALLMedicine™ Aa Amyloidosis Center

Research & Reviews  154 results

AA Amyloidosis in the Course of HIV Infection: A Report of 19 Cases Including 4 New Fre...
https://doi.org/10.1159/000516982
Nephron Breillat P, Pourcher V et. al.

Jul 16th, 2021 - HIV infection has been recently retained as an unclear cause of AA amyloidosis. Our aim was to investigate cases of AA amyloidosis associated with HIV infection to understand if it could be considered as a cause of AA amyloidosis. A comprehensive ...

A Case of Cyclic Neutropenia and Associated Amyloidosis.
https://doi.org/10.1097/MPH.0000000000002217
Journal of Pediatric Hematology/oncology; Ilonze C, Galipp KM et. al.

Jul 6th, 2021 - Cyclic neutropenia has been rarely associated with chronic inflammation and development of reactive AA amyloidosis. We report a family with cyclic neutropenia with associated renal and thyroid amyloid. A 12-year-old female presented with thyromega...

Survey of amyloidosis cases among different free-living wild and zoo animals.
https://doi.org/10.1080/13506129.2021.1940931
Amyloid : the International Journal of Experimental and C... Penticoff HB, Hipkiss HK et. al.

Jun 17th, 2021 - Amyloidosis comprises a range of protein-folding disorders characterised by a buildup of amyloid deposits in one or multiple organs. The pathogenesis and pathologic findings of amyloidosis can vary widely due to the nature of the precursor protein...

Membranous nephropathy associated with multicentric Castleman's disease that was succes...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191014
BMC Nephrology; Saiki R, Katayama K et. al.

Jun 11th, 2021 - Multicentric Castleman's disease is a life-threatening disorder involving a systemic inflammatory response and multiple organ failure caused by the overproduction of interleukin-6. Although renal complications of Castleman's disease include AA amy...

Two cases of secondary AA amyloidosis involving the skin and chronic kidney infection w...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186760
BMJ Case Reports; Garo F, Chatelain J et. al.

Jun 9th, 2021 - We present two French cases of amyloid-associated (AA) amyloidosis secondary to chronic infections. Patient 1, a 51-year-old heroin addict, was hospitalised for chest pain and anasarca. During hospitalisation, a nephrotic syndrome with an inflamma...

see more →

Clinicaltrials.gov  2 results

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
https://clinicaltrials.gov/ct2/show/NCT01215747

Mar 10th, 2016 - The primary purpose of this study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA Amyloidosis.

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
https://clinicaltrials.gov/ct2/show/NCT00035334

Feb 14th, 2006 - AA amyloidosis is associated with chronic inflammatory conditions (rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease), chronic infection (tuberculosis, osteomyelitis), and Familial Mediterranean Fever. Rheumatoid arthritis i...

see more →

News  4 results

Fast Five Quiz: How Much Do You Know About Amyloidosis?
https://reference.medscape.com/viewarticle/903213_3

Nov 2nd, 2018 - Immunoglobulin light chain amyloidosis (AL) is the most common type of systemic amyloidosis in the United States, with an estimated 12,000 US adults currently living with the condition. Outside of the United States, AA amyloidosis is more common t...

Rely on Colchicine for FMF, Experts Say
https://www.medpagetoday.com/rheumatology/generalrheumatology/55872

Jan 27th, 2016 - Action Points An international group of experts has formulated new recommendations for the management of the autoinflammatory condition known as familial Mediterranean fever, focusing principally on the use of colchicine to prevent both acute atta...

Familial Mediterranean Fever
https://www.medscape.com/viewarticle/450325_1

Abstract and Introduction Background: The pathogenesis of familial Mediterranean fever (FMF) is unknown, and since no specific laboratory test is yet available, the diagnosis of FMF remains clinical. The purpose of this study was to review clinica...

AL Amyloidosis: Advances in Diagnostics and Treatment
https://www.medscape.com/viewarticle/918626

Abstract and Introduction Abstract AL amyloidosis (light chain; previously also called primary amyloidosis) is a systemic disease characterized by an amyloid deposition process affecting many organs, and which still has unsatisfactory survival of ...

see more →

Patient Education  2 results see all →